APA (7th ed.) Citation

Rujirachaivej, P., Siriboonpiputtana, T., Choomee, K., Supimon, K., Sangsuwannukul, T., Songprakhon, P., . . . Yenchitsomanus, P. (2025). Engineered T cells secreting αB7-H3-αCD3 bispecific engagers for enhanced anti-tumor activity against B7-H3 positive multiple myeloma: A novel therapeutic approach. Journal of Translational Medicine, 23(1), 1. https://doi.org/10.1186/s12967-024-05923-z

Chicago Style (17th ed.) Citation

Rujirachaivej, Punchita, et al. "Engineered T Cells Secreting αB7-H3-αCD3 Bispecific Engagers for Enhanced Anti-tumor Activity Against B7-H3 Positive Multiple Myeloma: A Novel Therapeutic Approach." Journal of Translational Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12967-024-05923-z.

MLA (9th ed.) Citation

Rujirachaivej, Punchita, et al. "Engineered T Cells Secreting αB7-H3-αCD3 Bispecific Engagers for Enhanced Anti-tumor Activity Against B7-H3 Positive Multiple Myeloma: A Novel Therapeutic Approach." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12967-024-05923-z.